NSE - Delayed Quote INR

Sequent Scientific Limited (SEQUENT.NS)

Compare
179.63 -9.46 (-5.00%)
At close: 3:30 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
14,267,310.00
13,697,310.00
14,209,090.00
14,101,720.00
13,520,350.00
--
Cost of Revenue
7,792,270.00
7,597,470.00
8,337,670.00
8,444,360.00
7,365,620.00
--
Gross Profit
6,475,040.00
6,099,840.00
5,871,420.00
5,657,360.00
6,154,730.00
--
Operating Expense
5,935,820.00
6,022,920.00
6,140,950.00
4,983,410.00
4,402,510.00
--
Operating Income
539,220.00
76,920.00
-269,530.00
673,950.00
1,752,220.00
--
Net Non Operating Interest Income Expense
-539,860.00
-480,860.00
-355,170.00
-155,330.00
-237,570.00
--
Pretax Income
130,340.00
-546,460.00
-1,376,681.00
529,300.00
1,366,290.00
--
Tax Provision
-10,930.00
-250,330.00
-156,810.00
81,660.00
321,770.00
--
Net Income Common Stockholders
54,910.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
--
Diluted NI Available to Com Stockholders
54,910.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
--
Basic EPS
0.22
-1.44
-4.88
1.65
3.87
--
Diluted EPS
0.22
-1.44
-4.88
1.63
3.85
--
Basic Average Shares
249,454.29
249,090.28
248,276.64
247,408.75
246,879.75
--
Diluted Average Shares
249,454.29
249,090.28
248,276.64
250,733.25
247,870.49
--
Rent Expense Supplemental
--
--
34,040.00
19,940.00
10,410.00
6,850.00
Total Expenses
13,728,090.00
13,620,390.00
14,478,620.00
13,427,770.00
11,768,130.00
--
Net Income from Continuing & Discontinued Operation
54,910.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
--
Normalized Income
53,153.00
-182,227.00
-488,730.92
411,469.74
1,019,677.72
--
Interest Income
--
--
12,090.00
2,410.00
6,260.00
15,030.00
Interest Expense
539,860.00
480,860.00
355,170.00
135,090.00
192,540.00
--
Net Interest Income
-539,860.00
-480,860.00
-355,170.00
-155,330.00
-237,570.00
--
EBIT
670,200.00
-65,600.00
-1,021,511.00
664,390.00
1,558,830.00
--
EBITDA
1,305,700.00
549,800.00
-464,581.00
1,179,800.00
2,064,810.00
--
Reconciled Cost of Revenue
7,792,270.00
7,597,470.00
8,337,670.00
8,444,360.00
7,365,620.00
--
Reconciled Depreciation
635,500.00
615,400.00
556,930.00
515,410.00
505,980.00
--
Net Income from Continuing Operation Net Minority Interest
54,910.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
--
Total Unusual Items Excluding Goodwill
2,510.00
-252,090.00
-815,780.00
-2,270.00
-85,360.00
--
Total Unusual Items
2,510.00
-252,090.00
-815,780.00
-2,270.00
-85,360.00
--
Normalized EBITDA
1,303,190.00
801,890.00
351,199.00
1,182,070.00
2,150,170.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
753.00
-75,627.00
-92,920.92
-350.26
-20,102.28
--
3/31/2020 - 3/10/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers